ANTIGEN-SPECIFIC T-CELL ACTIVATION--VACCINES FOR MALARIA/AIDS

抗原特异性 T 细胞激活——疟疾/艾滋病疫苗

基本信息

项目摘要

We studied the mechanisms by which T cells recognize antigens presented on the surface of other cells in association with major histocompatibility complex (MHC)-encoded molecules, and the application of these principles to the design of synthetic vaccines for AIDS, malaria, and cancer. We have been able to quantitate the requirements for class I MHC molecules and for antigenic peptide for stimulation of CD8+ cytotoxic T lymphocytes (CTL) using purified class I molecules on plastic. The titration curves for peptide and for MHC were interdependent; no accessory molecules were necessary; excess beta-2 microglobulin is necessary for peptide binding; conversely, peptide stabilizes association of beta-2 with MHC heavy chains. In studying HIV- specific CTL epitopes, we found that human CTL from HIV infected individuals recognized four peptides from the envelope in association with HLA-A2. One of these was a dominant CTL epitope in the mouse, but 3 had been identified as helper epitopes. Conversely, we found that the CTL epitope in the mouse also stimulated CD4+ helper T cells. To test the extent of this promiscuity of peptides for multiple MHC molecules, we studied three peptides in mice of 10 MHC types, and found that each was presented with several class I MHC molecules. Also class I-MHC presented CTL epitopes from HIV reverse transcriptase and the malaria circumsporozoite protein were also presented by class II MHC molecules to helper T cells. Use of this concordance between helper and CTL epitopes in vaccine design is being explored. To overcome the problem of MHC polymorphism in the human population, we showed that peptides spanning multideterminant regions of HIV gp160 were recognized by mice of multiple MHC types and by T cells from a large fraction of humans. We also found that IL-2 production in response to gp160 peptides may be an earlier diagnostic for infection or at least exposure to HIV than antibody responses. We have also begun to search for tumor infiltrating CTL specific for mutant oncogene products in human cancers and animal models, with the aim of developing peptide immunotherapy to induce such CTL.
我们研究了T细胞识别抗原的机制

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

J A BERZOFSKY其他文献

J A BERZOFSKY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('J A BERZOFSKY', 18)}}的其他基金

ANTIGEN SPECIFIC T CELL ACTIVATION, APPLICATION TO VACCINES FOR CANCER AND AIDS
抗原特异性 T 细胞激活,在癌症和艾滋病疫苗中的应用
  • 批准号:
    3752001
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
ANTIGEN SPECIFIC T CELL ACTIVATION, APPLICATION TO VACCINES FOR CANCER AND AIDS
抗原特异性 T 细胞激活,在癌症和艾滋病疫苗中的应用
  • 批准号:
    3796428
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
ANTIGEN SPECIFIC T CELL ACTIVATION, APPLICATION TO VACCINES FOR CANCER AND AIDS
抗原特异性 T 细胞激活,在癌症和艾滋病疫苗中的应用
  • 批准号:
    2456830
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
ANTIGEN-SPECIFIC T-CELL ACTIVATION AND GENETIC CONTROL OF IMMUNE RESPONSES
抗原特异性 T 细胞激活和免疫反应的基因控制
  • 批准号:
    3962927
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
ANTIGEN SPECIFIC T CELL ACTIVATION, APPLICATION TO VACCINES FOR CANCER AND AIDS
抗原特异性 T 细胞激活,在癌症和艾滋病疫苗中的应用
  • 批准号:
    6123644
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
ANTIGEN SPECIFIC T CELL ACTIVATION, APPLICATION TO VACCINES FOR CANCER AND AIDS
抗原特异性 T 细胞激活,在癌症和艾滋病疫苗中的应用
  • 批准号:
    5200916
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
ANTIGEN-SPECIFIC T-CELL ACTIVATION AND GENETIC CONTROL OF IMMUNE RESPONSES
抗原特异性 T 细胞激活和免疫反应的基因控制
  • 批准号:
    3916273
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
GENETIC CONTROL OF THE IMMUNE RESPONSE TO NATURAL ANTIGENS
对天然抗原免疫反应的基因控制
  • 批准号:
    4691741
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
ANTIGEN SPECIFIC T CELL ACTIVATION, APPLICATION TO VACCINES FOR CANCER AND AIDS
抗原特异性 T 细胞激活,在癌症和艾滋病疫苗中的应用
  • 批准号:
    6163260
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
ANTIGEN SPECIFIC T CELL ACTIVATION, APPLICATION TO VACCINES FOR CANCER AND AIDS
抗原特异性 T 细胞激活,在癌症和艾滋病疫苗中的应用
  • 批准号:
    3774286
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Basic and applied study on AIDS-therapy using hybrid liposomes
混合脂质体治疗艾滋病的基础与应用研究
  • 批准号:
    24656509
  • 财政年份:
    2012
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
SIV MODEL FOR MULTI DRUG RESISTANCE TO AIDS THERAPY
艾滋病治疗多重耐药性的 SIV 模型
  • 批准号:
    6940442
  • 财政年份:
    2003
  • 资助金额:
    --
  • 项目类别:
RT-SHIV MODEL FOR RESISTANCE TO AIDS THERAPY
艾滋病治疗抵抗力的 RT-SHIV 模型
  • 批准号:
    6940441
  • 财政年份:
    2003
  • 资助金额:
    --
  • 项目类别:
Mitochondrial Toxicity of Antiviral Nucleosides in AIDS Therapy
艾滋病治疗中抗病毒核苷的线粒体毒性
  • 批准号:
    7421121
  • 财政年份:
    2002
  • 资助金额:
    --
  • 项目类别:
TARGETED MANIPULATION OF STEM CELLS FOR AIDS THERAPY
干细胞的靶向操作用于艾滋病治疗
  • 批准号:
    6312501
  • 财政年份:
    2001
  • 资助金额:
    --
  • 项目类别:
TARGETED MANIPULATION OF STEM CELLS FOR AIDS THERAPY
干细胞的靶向操作用于艾滋病治疗
  • 批准号:
    6499098
  • 财政年份:
    2001
  • 资助金额:
    --
  • 项目类别:
Targeted Manipulation of Stem Cells for AIDS Therapy
干细胞的靶向操作用于艾滋病治疗
  • 批准号:
    7479315
  • 财政年份:
    2001
  • 资助金额:
    --
  • 项目类别:
Targeted Manipulation of Stem Cells for AIDS Therapy
干细胞的靶向操作用于艾滋病治疗
  • 批准号:
    7666728
  • 财政年份:
    2001
  • 资助金额:
    --
  • 项目类别:
TARGETED MANIPULATION OF STEM CELLS FOR AIDS THERAPY
干细胞的靶向操作用于艾滋病治疗
  • 批准号:
    6708893
  • 财政年份:
    2001
  • 资助金额:
    --
  • 项目类别:
TARGETED MANIPULATION OF STEM CELLS FOR AIDS THERAPY
干细胞的靶向操作用于艾滋病治疗
  • 批准号:
    6849724
  • 财政年份:
    2001
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了